DE3431861A1 - Pellet-zubereitung - Google Patents

Pellet-zubereitung

Info

Publication number
DE3431861A1
DE3431861A1 DE19843431861 DE3431861A DE3431861A1 DE 3431861 A1 DE3431861 A1 DE 3431861A1 DE 19843431861 DE19843431861 DE 19843431861 DE 3431861 A DE3431861 A DE 3431861A DE 3431861 A1 DE3431861 A1 DE 3431861A1
Authority
DE
Germany
Prior art keywords
pellet
active ingredient
enteric
pellet preparation
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843431861
Other languages
German (de)
English (en)
Inventor
Hans Dieter Dr. 5060 Bergisch Gladbach Dell
Reinhold 5000 Köln Kraus
Detlef Dr. 5205 St Augustin Schierstedt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Priority to DE19843431861 priority Critical patent/DE3431861A1/de
Priority to CN198585102343A priority patent/CN85102343A/zh
Priority to NO853249A priority patent/NO853249L/no
Priority to EP85110362A priority patent/EP0173210B1/de
Priority to DE8585110362T priority patent/DE3577654D1/de
Priority to AT85110362T priority patent/ATE52688T1/de
Priority to AU46570/85A priority patent/AU4657085A/en
Priority to IL76201A priority patent/IL76201A0/xx
Priority to FI853296A priority patent/FI853296L/fi
Priority to CA000489611A priority patent/CA1255223A/en
Priority to PT81039A priority patent/PT81039B/pt
Priority to ZA856597A priority patent/ZA856597B/xx
Priority to KR1019850006235A priority patent/KR860001591A/ko
Priority to GR852101A priority patent/GR852101B/el
Priority to HU853287A priority patent/HUT39607A/hu
Priority to DK394685A priority patent/DK163208C/da
Priority to JP60190021A priority patent/JPH0759501B2/ja
Publication of DE3431861A1 publication Critical patent/DE3431861A1/de
Priority to US07/286,421 priority patent/US4900557A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19843431861 1984-08-30 1984-08-30 Pellet-zubereitung Withdrawn DE3431861A1 (de)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DE19843431861 DE3431861A1 (de) 1984-08-30 1984-08-30 Pellet-zubereitung
CN198585102343A CN85102343A (zh) 1984-08-30 1985-04-01 制备药丸制剂的方法
NO853249A NO853249L (no) 1984-08-30 1985-08-16 Pellet-preparat.
EP85110362A EP0173210B1 (de) 1984-08-30 1985-08-19 Pellet-Zubereitung
DE8585110362T DE3577654D1 (de) 1984-08-30 1985-08-19 Pellet-zubereitung.
AT85110362T ATE52688T1 (de) 1984-08-30 1985-08-19 Pellet-zubereitung.
AU46570/85A AU4657085A (en) 1984-08-30 1985-08-22 High density, delayed release lacquered pharmaceutical pellets
IL76201A IL76201A0 (en) 1984-08-30 1985-08-27 Pellet formulation and its preparation
CA000489611A CA1255223A (en) 1984-08-30 1985-08-28 Pellet formulation
FI853296A FI853296L (fi) 1984-08-30 1985-08-28 Pellet-produkt.
PT81039A PT81039B (pt) 1984-08-30 1985-08-28 Processo para a preparacao de formulacoes constituidas por granulos esfericos
ZA856597A ZA856597B (en) 1984-08-30 1985-08-29 Pellet formulation
KR1019850006235A KR860001591A (ko) 1984-08-30 1985-08-29 펠렛 제제물 및 그의 제조방법
GR852101A GR852101B (enExample) 1984-08-30 1985-08-29
HU853287A HUT39607A (en) 1984-08-30 1985-08-29 Process for producing pellet-composition
DK394685A DK163208C (da) 1984-08-30 1985-08-29 Retard-praeparat af acemetacin og fremgangsmaade til fremstilling deraf
JP60190021A JPH0759501B2 (ja) 1984-08-30 1985-08-30 ペレツト製剤
US07/286,421 US4900557A (en) 1984-08-30 1988-12-19 Pellet formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843431861 DE3431861A1 (de) 1984-08-30 1984-08-30 Pellet-zubereitung

Publications (1)

Publication Number Publication Date
DE3431861A1 true DE3431861A1 (de) 1986-03-13

Family

ID=6244255

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19843431861 Withdrawn DE3431861A1 (de) 1984-08-30 1984-08-30 Pellet-zubereitung
DE8585110362T Expired - Lifetime DE3577654D1 (de) 1984-08-30 1985-08-19 Pellet-zubereitung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8585110362T Expired - Lifetime DE3577654D1 (de) 1984-08-30 1985-08-19 Pellet-zubereitung.

Country Status (16)

Country Link
US (1) US4900557A (enExample)
EP (1) EP0173210B1 (enExample)
JP (1) JPH0759501B2 (enExample)
KR (1) KR860001591A (enExample)
AT (1) ATE52688T1 (enExample)
AU (1) AU4657085A (enExample)
CA (1) CA1255223A (enExample)
DE (2) DE3431861A1 (enExample)
DK (1) DK163208C (enExample)
FI (1) FI853296L (enExample)
GR (1) GR852101B (enExample)
HU (1) HUT39607A (enExample)
IL (1) IL76201A0 (enExample)
NO (1) NO853249L (enExample)
PT (1) PT81039B (enExample)
ZA (1) ZA856597B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265061B1 (en) * 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
JPH06508371A (ja) 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ 経口投与できる治療用タンパク質及びその製法
IT1251153B (it) * 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
DK0603992T4 (da) * 1992-12-22 2001-03-05 Univ Cincinnati Oral indgivelse af immunologisk aktive biomolekyler og andre terapeutiske proteiner
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AU783656B2 (en) 1999-09-02 2005-11-24 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
EP1339395A2 (en) 2000-11-28 2003-09-03 Fmc Corporation Edible pga (propylene glycol alginate) coating composition
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
CA2529984C (en) * 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
CN100336501C (zh) * 2003-08-06 2007-09-12 健乔信元医药生技股份有限公司 醋炎痛缓释性圆粒组成物及制备方法
EP1753405A4 (en) * 2004-06-10 2008-09-17 Glatt Air Tech Inc SLOW RELEASE PHARMACEUTICAL PREPARATION
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
BRPI0611342A2 (pt) 2005-04-29 2010-08-31 Tendix Dev Llc motor de combustão interna
US20080213339A1 (en) * 2005-08-02 2008-09-04 Roger Imboden Pharmaceutical Composition Containing Indometacin and/or Acemetacin
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
WO2019199246A1 (en) 2018-04-13 2019-10-17 Santa Farma İlaç Sanayi̇ A.Ş. A sustained release formulation comprising acemetacin with bimodal in vitro release
JP7125791B2 (ja) 2018-05-23 2022-08-25 シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド 活性薬物成分の放出制御システムおよびその製造方法
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
EP3796904B1 (en) 2018-11-16 2023-01-25 Santa Farma Ilaç Sanayi A.S. Sustained release acemetacin compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801203A (en) * 1951-03-22 1957-07-30 Byk Gulden Lomberg Chem Fab X-ray method of digestive enzyme diagnosis using protected core of contrast agent
IT628280A (enExample) * 1956-11-05
US3017329A (en) * 1957-08-15 1962-01-16 Dow Chemical Co Method of locating enteric constrictions with a plurality of pills containing an x-ray contrast agent
US3065142A (en) * 1958-07-30 1962-11-20 Armour Pharma Gastric resistant medicinal preparation
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
JPS54138128A (en) * 1978-04-19 1979-10-26 Akiyama Jiyouzai Kk Double contrast medium for intestine
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH04225410A (ja) * 1990-12-27 1992-08-14 Hitachi Ltd 文書編集装置

Also Published As

Publication number Publication date
PT81039A (en) 1985-09-01
DE3577654D1 (de) 1990-06-21
EP0173210B1 (de) 1990-05-16
HUT39607A (en) 1986-10-29
CA1255223A (en) 1989-06-06
FI853296A7 (fi) 1986-03-01
EP0173210A2 (de) 1986-03-05
EP0173210A3 (en) 1987-05-13
FI853296L (fi) 1986-03-01
PT81039B (pt) 1987-12-30
DK163208B (da) 1992-02-10
US4900557A (en) 1990-02-13
ZA856597B (en) 1986-04-30
FI853296A0 (fi) 1985-08-28
ATE52688T1 (de) 1990-06-15
JPS6165817A (ja) 1986-04-04
JPH0759501B2 (ja) 1995-06-28
AU4657085A (en) 1986-03-06
DK394685D0 (da) 1985-08-29
KR860001591A (ko) 1986-03-20
DK394685A (da) 1986-03-01
IL76201A0 (en) 1985-12-31
GR852101B (enExample) 1986-01-02
DK163208C (da) 1992-06-29
NO853249L (no) 1986-03-03

Similar Documents

Publication Publication Date Title
DE3431861A1 (de) Pellet-zubereitung
EP0068191B1 (de) Orale Dipyridamolformen
AT394310B (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
AT392901B (de) Verfahren zur herstellung einer granulaeren form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
EP0519870B1 (de) Neue orale Diclofenaczubereitung
EP0108898B1 (de) Neue orale Mopidamolformen
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
DE68910773T2 (de) Granulate mit Kern und ihre Herstellung.
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
EP1207867B1 (de) Retardierte, orale, pharmazeutische darreichnungsformen mit tramadol
EP0568577B1 (de) Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustände
DE68909772T2 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
EP0052076B1 (de) Schnellzerfallende Arzneimittel-Presslinge
DE20220415U1 (de) Tamsulosin-Tabletten
EP0387782A3 (de) Feste pharmazeutische Präparate und Verfahren zu ihrer Herstellung
EP0368216A1 (de) Feste pharmazeutische Retardform
EP1113787A1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
DE68903536T2 (de) Pharmazeutische granula und daraus hergestellte tabletten.
DE69816124T2 (de) Pharmazeutische zusammensetzungen enthaltend zafirlukast
EP1663162B1 (de) Oral zu applizierende darreichungsform für schwerlösliche saure und amphotere wirkstoffe
EP0381174B1 (de) Verfahren zur Herstellung fester pharmazeutischer Zubereitungen
EP1038527A1 (de) Verfahren zur Herstellung von Riboflavin-haltigen Granulaten
DE602006000402T2 (de) Stabile Zubereitung enthaltend eine feuchtigkeitsemphindliche aktive Substanz und Verfahren zur Herstellung der Zubereitung.
DE4317172A1 (de) Geschmacksneutrale und schnellfreisetzende Buflomedil-Hydrochlorid-Arzneiform und Herstellungsverfahren desselben
CH696870A5 (de) Orale pharmazeutische Tablettenformulierung.

Legal Events

Date Code Title Description
8130 Withdrawal